Cargando…
Effects of Semaglutide and Empagliflozin on Inflammatory Markers in Patients with Type 2 Diabetes
Low-grade inflammation is associated with complications of type 2 diabetes. Glucagon-like peptide-1 receptor agonists and sodium-glucose transporter-2 inhibitors have shown cardioprotective effects that are independent of their glucose-lowering effects. Cardio-protection could be mediated by the ant...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054691/ https://www.ncbi.nlm.nih.gov/pubmed/36982786 http://dx.doi.org/10.3390/ijms24065714 |